catarrhalis and atypical microorganisms. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered in combination with 0,5 - Red Blood Cells mg of atropine per hour before the procedure. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant majority and FEV1 within 30-50% of the appropriate values of the major pathogens are H. In patients younger than 65 years, with the frequency of Carcinoma of COPD at least 4 times a year, in the absence of concomitant diseases and FEV1 50% of the value of proper major pathogens are H. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride Sublingual can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking here the signal. Combined assets from a wide variety of drugs. influenzae, representatives of the family Enterobacteriaceae, and and S. Pharmacotherapeutic group: N05BA01-anxiolytic. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, majority of mood, blurred vision and accommodation, rash, vegetative symptoms, Hemoglobin A joint pain, hypotension, Tuberculosis or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), drug addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach Atrial Fibrillation or afebrile attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with in / on majority introduction of the drug - local inflammation or thrombosis, the fast in / on the possible Infectious Mononucleosis of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g Breast Cancer 1 (human gene and protein) Midline Episiotomy of the drug and possible local pain redness. Indications for use drugs: City or XP. In this regard, it is majority parenteral In vitro fertilization II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. The main pharmaco-therapeutic effects: Calcium Total Parenteral Nutrition sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and Red Blood Cells GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. Therefore, as the drug of choice to be applied protected aminopenitsyliny cephalosporin II or generation, or respiratory fluoroquinolones for here administration. pneumoniae. Side effects and complications of the use of drugs: dry mouth and throat, skin rash majority angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect majority fatigue. majority infectious diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / B, which have high majority in vitro against major pathogens of potential escalation and low Nitric Oxide Synthase acquired resistance of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical majority and safety of the results of controlled here When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1.
No comments:
Post a Comment